Statistics for Over-Prescription of Short-Acting β2-Agonists Remains a Serious Health Concern in Kenya: Results from the SABINA III Study
Total visits
| views | |
|---|---|
| Over-Prescription of Short-Acting β2-Agonists Remains a Serious Health Concern in Kenya: Results from the SABINA III Study | 3 |
Total visits per month
| views | |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 2 |
| May 2026 | 0 |
File Visits
| views | |
|---|---|
| Over-Prescription of Short-Acting β2-Agonists Remains a Serious Health Concern in Kenya....pdf | 96 |